Aptevo Therapeutics (APVO US)

Analysis

Health Care • United States

Aptevo Therapeutics Inc. operates as a biotechnology company. TheCompany provides oncology and hematology therapeutics. Aptevo Therapeutics serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00